SNYR Stock Analysis: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$1.30
0.09 (7.44%)
▲
5d:
+15.04%
30d:
-6.47%
90d:
-28.18%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Mar 31, 2026
0d
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNYR trading at deep discount. Market pricing in -10.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SNYR trading at deep discount. Market pricing in -10.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.62
Based on 9.4% avg growth
INTRINSIC VALUE TODAY
$1.62
19.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $1.30, which is considered fair relative to its 30-day fair value range of $1.22 to $1.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.9) compared to its historical average (5.4). Remarkably, the market is currently pricing in an annual earnings decline of 10.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.99, while resistance sits at $1.38. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+395.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.99, while resistance sits at $1.38. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+395.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.22 -
$1.37
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.4%)
- BULLISH: Trading 395.9% below Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$1.22 -
$1.37
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.99
Resistance Level
$1.38
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.90
Wall Street Target
$6.00
(+395.9%)
Revenue Growth (YoY)
12.4%
Earnings Growth (YoY)
-90.6%
Profit Margin
7.5%
Valuation Discount vs History
-10.5% cheaper
PE vs Historical
3.9 vs 5.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.5%
(market-implied from PE analysis)
1-Year Target
$1.09
(-10%)
2-Year Target
$0.98
(-19%)
3-Year Target
$0.88
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→5)
$1.22
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 14.8%)
$10.49
(+767%)
Base:
(SPY PE: 3.9, Growth: 14.8%)
$1.83
(+51%)
Bear:
(PE: 3.3, Growth: 14.8%)
$1.56
(+29%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (4x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 4.36 | Current EPS (TTM): $0.28
Bull Case
$1.49
(+27%)
Analyst growth 10.7%, PE expands to 4.8
Base Case
$1.35
(+15%)
Market implied 10.7%, PE stable at 4.4
Bear Case
$0.83
(-29%)
Severe decline -20.0%, PE contracts to 3.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.9 to 5.4
Stabilization Target:
$1.67
(+38.3%)
PE Expansion Potential:
+38.3%
Share & Embed Analysis
Last updated: March 31, 2026 12:46 PM ET
Data refreshes hourly during market hours. Next update: 1:46 PM
Data refreshes hourly during market hours. Next update: 1:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$998 | 61 BUY |
|
COR
Cencora Inc. |
BUY
17 analysts |
$410 | 59 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$250 | 52 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$90 | 60 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
